Stockscreener 앱 받기
0.3477
1.37%
0.0047
시간 외 거래:
.34
-0.0077
-2.21%
Bioaffinity Technologies Inc 주식(BIAF)의 최신 뉴스
bioAffinity’s CyPath® Lung Test Identifies Missed Tumor - TipRanks
What analysts say about bioAffinity Technologies Inc. stockSuperior profit margins - Autocar Professional
Breakthrough: New Lung Cancer Test Catches Hidden Stage 1A Tumor Other Diagnostics Missed - Stock Titan
The BIAF Stock Puzzle: Unraveling BioAffinity Technologies Inc’s Fluctuating Performance - investchronicle.com
Is bioAffinity Technologies Inc. Equity Warrant a good long term investmentHigh-yield investments - jammulinksnews.com
Canada Awards New Patent to bioAffinity Technologies for CyPath® Lung, Company’s Noninvasive Lung Cancer Diagnostic - BioSpace
bioAffinity Technologies obtains Canadian patent for lung cancer spit test - Mugglehead Magazine
Is bioAffinity Technologies Inc. a good long term investmentLightning-fast capital gains - jammulinksnews.com
What drives bioAffinity Technologies Inc. stock priceConsistently profitable trades - Autocar Professional
What drives bioAffinity Technologies Inc. Equity Warrant stock priceExceptional risk-adjusted gains - jammulinksnews.com
bioAffinity Technologies Secures Canadian Patent for Lung Cancer Detection - TipRanks
What analysts say about bioAffinity Technologies Inc. Equity Warrant stockUnmatched market gains - jammulinksnews.com
Published on: 2025-07-22 10:16:37 - Newser
bioAffinity Technologies secures Canadian patent for lung cancer test By Investing.com - Investing.com India
bioAffinity Technologies Inc. Equity Warrant Stock Analysis and ForecastHigh-impact stock picks - jammulinksnews.com
Why bioAffinity Technologies Inc. stock is on top investor watchlistsFree Investment Community - Newser
bioAffinity Technologies Inc. Stock Analysis and ForecastOutstanding stock performance - jammulinksnews.com
Published on: 2025-07-17 23:17:46 - Newser
bioAffinity Technologies Secures Chinese Patent for Lung Cancer Detection - The Globe and Mail
Before You Invest, Make Sure You Check This BioAffinity Technologies Inc (NASDAQ: BIAF) Analysis - Stocksregister
Why bioAffinity Technologies Inc. Equity Warrant stock attracts strong analyst attentionExpert Backed Predictions - Newser
bioAffinity Technologies Announces Notification of China Patent Award for Company’s Noninvasive Lung Cancer Diagnostic - BioSpace
How bioAffinity Technologies Inc. Equity Warrant stock performs during market volatilityAI Powered Stock Call - Newser
bioAffinity receives patent award for lung cancer diagnostic in China. - AInvest
2.84%
1.50%
자본화:
|
볼륨(24시간):